Get the Stockscreener App
3.01
0.33%
-0.01
After Hours:
3.02
0.01
+0.33%
Bionano Genomics Inc stock is traded at $3.01, with a volume of 73,043.
It is down -0.33% in the last 24 hours and down -8.23% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$3.02
Open:
$3.01
24h Volume:
73,043
Relative Volume:
0.74
Market Cap:
$10.13M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.1693
EPS:
-17.78
Net Cash Flow:
$-126.87M
1W Performance:
-13.01%
1M Performance:
-8.23%
6M Performance:
-42.00%
1Y Performance:
-92.18%
1-Day Range:
$2.99
$3.2066
1-Week Range:
$2.99
$3.49
52-Week Range:
$2.68
$39.59
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
3.01 | 10.16M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
481.09 | 179.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
178.25 | 52.03B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.55 | 44.11B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
271.94 | 40.68B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.26 | 17.92B | 2.90B | 467.20M | 306.90M | 6.37 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Does Bionano Genomics Inc. stock perform well during market downturnsDaily Trading Signals That Work - jammulinksnews.com
Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025 - The Manila Times
What makes Bionano Genomics Inc. stock price move sharplyLow Risk Growth Plan With Low Risk - jammulinksnews.com
Bionano Recaps Momentum behind Optical Genome Mapping at the Biennial Meeting of the European Cytogenomics Association Held Recently in Leuven, Belgium | BNGO Stock News - GuruFocus
Bionano Recaps Momentum behind Optical Genome Mapping at the Biennial Meeting of the European Cytogenomics Association Held Recently in Leuven, Belgium - The Manila Times
Bionano Genomics Inc. Recovery Linked to Earnings SurpriseCommunity Verified Stock Suggestions Drive Volume - metal.it
Optical Genome Mapping Studies Surge 78% at European Genetics Conference | BNGO Stock News - Stock Titan
Investors Continue Waiting On Sidelines For Bionano Genomics, Inc. (NASDAQ:BNGO) - simplywall.st
Why Bionano Genomics Inc. stock attracts strong analyst attentionInvestment Plan With Growth Optimization Finalized - beatles.ru
Is Now a Good Time to Reenter Bionano Genomics Inc.Weekly Growth Stock Entry Point Alerts Highlighted - metal.it
How did BNGO's revenue and expenses trend in Q4 2024? - AInvest
Intraday Charts Show Spike in Bionano Genomics Inc. ActivityEarnings Play Trade Plan With Alerts Shared - metal.it
What is the risk reward ratio of investing in Bionano Genomics Inc. stockExpert Picks Report For Fast Growth - jammulinksnews.com
Why is Bionano Genomics Inc. stock attracting strong analyst attentionDaily Trading Ideas For Fast Growth - jammulinksnews.com
What are the technical indicators suggesting about Bionano Genomics Inc.Stock Market Entry Points To Watch Now - jammulinksnews.com
What makes Bionano Genomics Inc. stock price move sharply Volatility Analysis and Entry Risk Mapping - metal.it
How volatile is Bionano Genomics Inc. stock compared to the marketBuild wealth faster with high-performing stocks - jammulinksnews.com
What institutional investors are buying Bionano Genomics Inc. stockAchieve consistent profits with proven methods - jammulinksnews.com
What catalysts could drive Bionano Genomics Inc. stock higher in 2025Triple-digit return opportunities - jammulinksnews.com
Is it the right time to buy Bionano Genomics Inc. stockTriple-digit growth rates - jammulinksnews.com
Is Bionano Genomics Inc. stock overhyped or has real potentialUnmatched market gains - jammulinksnews.com
Is Bionano Genomics Inc. a good long term investmentOutstanding capital appreciation - PrintWeekIndia
What analysts say about Bionano Genomics Inc. stockSuperior stock selection - Autocar Professional
What drives Bionano Genomics Inc. stock priceFast-track wealth growth - PrintWeekIndia
Should I buy Bionano Genomics Inc. stock before earningsBreakthrough stock performance - jammulinksnews.com
Bionano Genomics Inc. Stock Analysis and ForecastBreakthrough profits - Autocar Professional
How To Trade (BNGO) - news.stocktradersdaily.com
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
22.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):